A prospective, randomised, single blind, and controlled trial of a hypnotic technique was undertaken in 39 adults with mild to moderate asthma gradad for low and high susceptibility to hypnosis. After a six week course of hypnotherapy 12 patients with a high susceptibility score showed a 74-9% improvement (p<O0Ol) in the degree of bronchial hyper-responsiveness to a standardised methacholine challenge test. Daily home recordings of symptoms improved by 41% (p<OOl), peak expiratory flow rates improved by 5-5% (p<OOl), and use of bronchodilators decreased by 26-2% (p<005). The improvement in bronchial hyper-reactivity occurred without a change in subjective appreciation of the degree of bronchoconstriction. A control group 17 patients and 10 patients undergoing treatment with low susceptibility to hypnosis had no change in either bronchial hyper-responsiveness or any of the symptoms recorded at home.
Introduction
Although orthodox medical practice offers numerous effective treatments, patients with asthma continue to seek relief from a variety of alternative regimens, which have achieved widespread acceptability despite the lack of conventional proof of efficacy. ' Several psychosomatic studies have suggested that hypnosis or relaxation, or both, may be useful in the treatment of asthma.2 16 The reported success of these studies is questionable owing to the lack of matched control groups and appropriate physiological and psychological measurements. No study has investigated whether any apparent improvement is a result of a decrease in bronchial responsiveness or simply a decrease in awareness of the degree of bronchoconstriction. The latter possibility could endanger life if it resulted in delay or failure to seek effective treatment in an attack of asthma.
We report a prospective, randomised, and controlled investigation into the efficacy of a hypnotic technique in a group of adults with mild to moderate asthma assessed by a standardised methacholine inhalation challenge test.
Patients and methods
Forty four patients with a history of mild to moderate asthma were recruited from the local community. Patients were aged between 18 and 45 years and all gave a history of episodic wheeze or shortness of breath, or both. Each patient was told that the aim of the trial was to assess the possible benefit of a "relaxation technique" to control symptoms of asthma. The study was approved by the hospital ethical committee and the patients provided written informed consent.
The exclusion criteria were: a reduction of less than 20% in the ratio of forced expiratory volume in one second to forced vital capacity with the maximum concentration of metacholine; a history of severe asthma (prior admission to hospital which had required ventilatory support or admission with an arterial carbon dioxide pressure of more than 5 33 kPa (40 mmHg)); concurrent systemic steroid treatment; pregnancy; and a history of psychosis or relevant medical illness, including a history of bronchitis that fulfilled the standard criteria. " The patients were divided into two groups according to whether they showed low (score 0-2) or high (score 3-5) susceptibility to hypnosis on the Stanford hypnotic clinical scale.8 This is a short, clinically oriented test, which is easy to perform and consists of a progressive relaxation induction followed by the suggestions of moving hands together, a dream, age regression, a posthypnotic suggestion, and amnesia. It correlates well with the longer and standardised Stanford hypnotic susceptibility scales and the Harvard group scale of hypnotic susceptibility. 19 The senior outpatient nursing sister (who was not otherwise concerned with the trial) then randomised the patients of both groups independently into treatment and control groups.
All subjects completed a diary, which consisted of the following: peak expiratory flow rates measured twice daily using a Wright peak flow meter, daily use of drugs, and graded scores of five symptoms related to asthma (cough, activity limitation, wheeze, phlegm, and nocturnal symptoms). The hypnotic technique started with an introductory discussion, which combined an outline of the treatment procedures, a general description of hypnosis, and a hypnotic induction. This was followed by suggestions of progressive relaxation, ego enhancement, and a method of self hypnosis. The remaining five sessions began with a similar but shortened induction, followed by a progression of guided imageries. By the final two sessions symptoms of asthma could be rapidly produced and immediately resolved under the subject's own control. Psychological profiles included the statetrait anxiety inventory,2' Zung's self rating depression scale, 22 (table I) . Table II compares results of lung function tests in the control and treatment groups before and after treatment. Thee were no significant differences between the two groups in expiratory flow measurements, static lung volumes, or airways resistance before treatment. After treatment there was a small but significant improvement in the forced vital capacity in both the control and treatment groups of 5 03% and 6-9% respectively. In addition, the treatment group showed a significant improvement in both the peak expiratory flow rate and the maximum expiratory flow rate at 50% vital capacity after treatment of 11 7% and 14 -7% respectively.
The patients with high susceptibility to hypnosis who underwent the hypnotic technique showed a 7499% (p<001) improvement in bronchial hyper-responsiveness (table III) . Neither the low susceptibility treatment group nor the control group showed any improvement.
The subjective score during the methacholine challenge test correlated with the forced expiratory volume in one second (r=0 905, p<0002), with an overall mean (SD) change in forced expiratory volume in one second of Statistical significance between values before and after treatment using paired t test: *p<005;
tp<00l; tp<0 O1.
In the high susceptibility group the subjective scores for nocturnal symptoms, wheeze, and activity limitation and peak flow rates improved after treatment by 62% (p<005), 53% (p<001), 40% (p<001), and 5-5% (p<001) respectively. No significant change was found in either the low susceptibility treatment group or in the control group (table IV) . There was no change in the scores for cough and sputum production in any group. The use of inhaled bronchodilator drugs decreased from a mean of4-6 puffs a day to 3-4 puffs a day (p<005) in the high susceptibility treatment group but not in any of the other groups (table IV.) Discussion Despite the accepted importance of the psyche in asthma, scientific endeavour has been largely directed towards pharmacological techniques for treating asthma. The relatively few studies that have used hypnotic techniques have failed to provide adequare evidence for a significant therapeutic effect because of poor methods. In 1959 Diamond reported a 73% "complete remission of symptoms" without any objective documentation.3 MaherLoughnan et al reported that 59% of 127 patients were "much improved,"5 and in another, uncontrolled study 82% of 173 patients had a "convincing response to treatment."'" Both relied on symptom scores without objective evaluation of respiratory function. In an uncontrolled and retrospective study Collison8 reported that 21% of his treated patients were "drug free," and 33% had a "worthwhile decrease in frequency or severity of symptoms," but he also failed to measure respiratory function objectively.
Our study showed that a hypnotic technique had a significantly beneficial effect on bronchial hyper-responsiveness as measured by a methacholine inhalation challenge test. The improvement in patients' symptoms together with improvement in the peak expiratory flow rates and decreased use of inhaled sympathomimetic drugs indicate that the 74-9% improvement in bronchial hyperresponsiveness sensitivity is clinically important. That these improvements were confined to the group of patients with a high level of susceptibility to hypnosis who were receiving treatment and were not seen in the control group or those patients treated by hypnosis but who had a low susceptibility to it is entirely consistent with the suggestion that the benefit was due to the hypnotic technique alone rather than a non-specific effect. The pattern of response also suggests that the high and low susceptibility groups in this study may be the same as the "reactors" and "non-reactors" to 1131 suggestion that were identified in a group of patients with mild asthma by Strupp et al. 6 Clinical trials of psychosomatic treatments, where the use of truly blinded treatment is impossible, require careful elimination of bias in the recruitment, randomisation, and assessment methods. The use of four independent agencies for the various aspects of the trial (independent randomisation, separate control and treatment therapists, and blinded laboratory testing) is the best way to avoid the subtle selection processes that can invalidate conclusions. Analysis of susceptibility to hypnosis and psychological profiles, the details of which are to be reported elsewhere, showed no difference between the control and treatment groups and that the data were consistent with known population profiles.26
Although hypnotherapy is unlikely to have adverse effects, successful treatment might alter the patient's appreciation of the severity of the airways obstruction, leading to a delay in seeking appropriate emergency treatment. In the treatment group we took care to minimise this possibility by suggestions given during hypnosis of increased awareness of symptoms of asthma, attention to the need for appropriate action, and the avoidance of symptom denial. The highly susceptible patients showed no significant change in subjective sensitivity after treatment. Although subjective appreciation of bronchoconstriction during a methacholine challenge test cannot be equated with conditions in everyday life, our results indicate the relative safety of this hypnotic technique.
The mechanism of the psychosomatic response in asthma has not been established, nor has the cause of asthma itself. Philipp et al'2 proposed a model in which a shift in autonomic arousal induces a change in bronchial sensitivity to local stimuli such as inhaled allergens or non-specific irritants. In an asthma attack "self perception" of the bronchoconstriction will induce anxiety, which, if not accommodated successfully, will increase autonomic arousal and produce a positive feedback stimulus exacerbating the bronchoconstrictor response. Psychosomatic methods may act by directly decreasing the level of autonomic arousal, deconditioning the primary central stimulus, or inhibiting the positive "self perception" feedback loop. 27 There are several studies in animals and man which collectively provide strong indirect evidence of a cholinergic vagal pathway by which psychogenic stimuli may affect bronchial hypersensitivity. Suggestion appears to affect the larger airways,28 which is consistent with the known distribution of the vagus within the bronchial tree. 29 Direct stimulation of the vagus induces a heightened response to histamine challenge,a while in the guinea pig atropine blocks the classic Pavlovian conditioned bronchospasm, but not that induced by allergens.3' Atropine32 and ipratropium33 both decrease the bronchospasm induced by suggestion in patients with mild asthma. This model of psychogenic interaction with bronchial hyperresponsiveness is also consistent with the observation that atropine blocks morphine sensitive but not morphine insensitive bronchoconstriction. 34 Other pathways could be implicated, such as the recently described non-adrenergic, non-cholinergic bronchodilator system,35 but clear evidence will depend on the development of a specific neural blocker.
While our hypnotic technique does not eliminate bronchial hyper-responsiveness it does provide a clinically useful and nontoxic adjuvant to drug treatment that might benefit about half of the asthmatic population. In subjective terms the perception of control over the degree of bronchospasm, accompanied by diminished anxiety, often results in an enhanced feeling of health and confidence. Many patients reported that this sense of wellbeing paralleled improvements in other aspects of their lives such as general stress management, insomnia, and other psychosomatic symptoms.
We thank Tom Tanner, Maureen (13/14) , but 11 sera were positive for IgM and IgA classes, and five out of 14 positive sera also had the ability to fix complement. Absorption of sera positive for autoantibodies with an -IgA coupled immunoabsorbent did not modify the intensity of the staining, indicating that these antibodies were not directed against secretory IgA. High titres and the complement fixing ability of enterocyte autoantibodies indicated a poorer prognosis Introduction Protracted diarrhoea of infancy is due to a heterogeneous group of disorders in which the diagnosis can be identified in about 70% of the patients.' The remaining unexplained cases almost certainly represent a range of several different conditions and have a high mortality2; the average consultant paediatrician might see one such patient every year. Isolated cases of idiopathic protracted diarrhoea of infancy have been described in which-circulating autoantibodies to gut enterocytes have been shown by classic indirect inmmunofluorescence technique. These initial reports suggested that an autoimnmune disorder with characteristics similar to those described in other well recognised organ specific autoimmune diseases might account for some of the hitherto unexplained cases of protracted diarrhoea of infancy. We therefore investigated a larger senes of children affected by this condition to define a group of patients in whom this complex syndrome might be related to an autoimmune disorder.
Patients
Twenty five children (15 boys and 10 girls), aged 1 month to I year at the onset of symptoms, were investigated for unexplained protracted diarrhoea.
